Antibiotic Treatment for Lower Extremity Cellulitis
For typical uncomplicated lower extremity cellulitis without systemic signs, use an antibiotic active against streptococci such as cephalexin, penicillin, or amoxicillin for 5 days. 1
Treatment Algorithm Based on Clinical Severity
Mild Cellulitis (No Systemic Signs)
- First-line: Anti-streptococcal agents (strong recommendation)
- Cephalexin (preferred oral option) 2
- Penicillin
- Amoxicillin
- Duration: 5 days, extend only if not improving 1
- Setting: Outpatient management 1
Moderate Cellulitis (Systemic Signs Present)
- Coverage: Anti-streptococcal agents; many clinicians add MSSA coverage (weak recommendation) 1
- Consider hospitalization based on clinical judgment
Severe Cellulitis (High-Risk Features)
Add MRSA coverage with vancomycin or equivalent if ANY of these are present:
- Penetrating trauma
- Evidence of MRSA infection elsewhere
- Nasal MRSA colonization
- Injection drug use
- Purulent drainage
- SIRS (systemic inflammatory response syndrome) 1
Severely Compromised Patients
- Regimen: Vancomycin PLUS piperacillin-tazobactam OR imipenem-meropenem 1
- Hospitalization required
Critical Management Points Beyond Antibiotics
Examine interdigital toe spaces carefully - treating tinea pedis (fissuring, scaling, maceration) reduces recurrence risk 1. This is a commonly missed intervention that directly impacts outcomes.
Elevate the affected limb and address predisposing factors like edema or underlying skin conditions 1.
Important Clinical Caveats
Avoid Overtreatment
Broad-spectrum antibiotics are commonly overused in uncomplicated cellulitis without justification 3. The majority of non-purulent cases are caused by β-hemolytic streptococci or MSSA, not MRSA 2. Even with rising community-acquired MRSA rates, coverage is generally not recommended for typical non-purulent cellulitis 2.
Culture Considerations
- Do NOT routinely culture blood or skin in typical cases 1
- DO culture blood if systemic signs present 1
- Consider cultures in immunocompromised patients, chemotherapy recipients, neutropenia, immersion injuries, or animal bites 1
Hospitalization Criteria
Admit if patient has:
- SIRS, altered mental status, or hemodynamic instability
- Concern for deeper/necrotizing infection
- Poor adherence anticipated
- Severe immunocompromise 1
Evidence Quality Note
The IDSA 2014 guidelines 1 provide the strongest recommendations (strong, moderate-to-high quality evidence) and remain the authoritative source. Recent research 2, 3 confirms that narrow-spectrum antibiotics targeting streptococci are sufficient for uncomplicated cases, with no benefit from broader coverage. The 5-day duration recommendation is supported by high-quality evidence 1.